A COMBINED SINGLE AND MULTIPLE DOSE PHARMACOKINETIC STUDY OF ORAL ISOSORBIDE-5-MONONITRATE IN HEALTHY-VOLUNTEERS

被引:4
|
作者
STORM, G
OOSTERHUIS, B
BRON, J
WITTEBROOD, AJ
DEJONG, AP
JONKMAN, JHG
机构
[1] CEDONA PHARMACEUT BV,POB 850,2003 RW HAARLEM,NETHERLANDS
[2] PHARMA BIORES INT BV,9400 AC ASSEN,NETHERLANDS
关键词
ISOSORBIDE-5-MONONITRATE; NITRATES; PHARMACOKINETICS; SINGLE DOSE; MULTIPLE DOSE; RELATIVE BIOAVAILABILITY; PENTACARD; ISMO;
D O I
10.1002/bdd.2510120904
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacokinetics of 20 mg isosorbide-5-mononitrate (IS-5-MN) after single and multiple administration of two different tablet formulations were investigated in twelve healthy human subjects using an open, randomized, two-way crossover experimental design. Pentacard(R) 20 mg tablets were compared with Ismo(R) 20 mg tablets. After single-dose administration, both preparations caused a rapid increase in IS-5-MN plasma levels with the peak plasma concentration occurring between 0.5 and 1.5 h. For both formulations, the mean plasma half-life was found to be approximately 5 h after a single dose. In steady state during multiple dosing (t.i.d. at 8 h dosing intervals), a reduced elimination rate was observed. In line with this observation, the area under the plasma concentration-time curve (AUC) for one 8 h dosing interval during multiple dosing was higher than the extrapolated AUC after a single dose. Based on statistical evaluation of the various relevant pharmacokinetic parameters calculated from the plasma concentrations occurring after single and multiple dosing, the tablet formulations are judged to be bioequivalent.
引用
收藏
页码:661 / 672
页数:12
相关论文
共 50 条
  • [1] Aqueous humour flow after a single oral dose of isosorbide-5-mononitrate in healthy volunteers
    Kotikoski, H
    Oksala, O
    Vapaatalo, H
    Aine, E
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2003, 81 (04): : 355 - 360
  • [2] Single and multiple dose pharmacokinetic studies of oral sustained release and non-sustained release formulations of isosorbide-5-mononitrate in healthy volunteers
    Zhang, Q
    Huang, XF
    Ji, P
    Fu, LH
    Yan, BX
    Wei, SL
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (06): : 641 - 645
  • [3] EVALUATION OF BIOAVAILABILITY AND PHARMACOKINETICS OF 2 ISOSORBIDE-5-MONONITRATE PREPARATIONS IN HEALTHY-VOLUNTEERS
    HUTT, V
    THEODOR, R
    PABST, G
    BONN, R
    FRITSCHI, E
    JAEGER, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (06): : 553 - 557
  • [4] COMPARISON OF ANTIPLATETLET PROPERTIES OF MOLSIDOMINE, ISOSORBIDE-5-MONONITRATE AND PLACEBO IN HEALTHY-VOLUNTEERS
    DRUMMER, C
    VALTASEUFZER, U
    KARRENBROCK, B
    HEIM, JM
    GERZER, R
    EUROPEAN HEART JOURNAL, 1991, 12 (04) : 541 - 549
  • [5] EVALUATION OF THE PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILITY OF 3 ISOSORBIDE-5-MONONITRATE PREPARATIONS IN HEALTHY-VOLUNTEERS
    HUTT, V
    BONN, R
    FRITSCHI, E
    JAEGER, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (02): : 142 - 145
  • [6] PLATELET-AGGREGATION AND FIBRINOLYSIS IN HEALTHY-VOLUNTEERS AFTER ORAL INTAKE OF MOLSIDOMINE, ISOSORBIDE-5-MONONITRATE AND PLACEBO
    DRUMMER, C
    VALTASEUFZER, U
    SPANNAGL, M
    FREY, A
    LUDKE, S
    SCHRAMM, W
    GERZER, R
    ZEITSCHRIFT FUR KARDIOLOGIE, 1991, 80 : 43 - 46
  • [7] A PHARMACOKINETIC MODEL FOR ISOSORBIDEDINITRATE, ISOSORBIDE-2-MONONITRATE, AND ISOSORBIDE-5-MONONITRATE
    SMITH, D
    ALDRICH, W
    DEY, M
    ENEVER, R
    WARNER, R
    WEIERSTALL, R
    DRUG METABOLISM AND DISPOSITION, 1990, 18 (04) : 429 - 434
  • [8] PHARMACOKINETIC ASPECTS OF ISOSORBIDE-5-MONONITRATE IN DOGS
    SPONER, G
    KUHNLE, HF
    STREIN, K
    BARTSCH, W
    ENDELE, R
    DIETMANN, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1984, 228 (01): : 235 - 239
  • [9] The effect of orally single dose of slow-release isosorbide-5-mononitrate on central blood pressure in healthy volunteers
    Jiang, Xiongjing
    Wang, Ping
    Du, Shu-Xian
    Liu, Yu-Qing
    Li, Yi-Shi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S86 - S86
  • [10] Evaluation of the bioequivalence and pharmacokinetics of two tablet formulations of isosorbide-5-mononitrate after single oral administration in healthy volunteers
    Niopas, I
    Daftsios, AC
    Nikolaidis, N
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2002, 52 (03): : 182 - 186